A single case study of punarnavadi kashay and nirocil in hepatitis c viral load
Keywords:
Punarnavadi kashay,Tab Nirocil, Hepatitis CAbstract
Hepatitis C virus infection is the most common blood borne infection, its prevalence reaching upto 170 million worldwide. Most HCV infection persist and about 30% of the individuals with persistent infection develop chronic liver disease, including liver cirrhosis and hepatocellular carcinoma. Although HCV is curable, and antiviral HCV treatment leading to viral eradication reduces liver related morbidity and mortality ,treatment with pegylated interferone plus ribavarin is burdensome ,toxic, expensive, and ineffective for half of those who attempt the therapy. Clinical presentation of HCV shows jaundice, stomach pain, loss of appetite, Nausea, fatigue, myalgia, etc. To counter these entities, drugs having anti-viral and hepatoprotective activity should be administered .In present study 57 yrs old male was enrolled who was infected by HCV prior to our consulting. He was administered Punarnavadi kashay with gomutra in a dose of 80ml into 2 divided doses with warm water after food and Tab Nirocil in a dose of 3 tablets thrice a day before food. Biochemical parameters like Hepatitis C Virus RNA Quantitative analysis was done before and at the end of the trial. Observed results were graded on 4 grade scale and were analyzed before and after the follow-up of 1 month interval for 5 months. Study drug was found to be effective in alleviating most of the symptoms along with desired changes in biochemical markers. To conclude it more firmly, specific targeted study has to be conducted with required modulations.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurline.in and online filled (uploaded) form.
Please read following declaration cum Agreement Carefully.:
I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein.
I (We) agree (on behalf of me and my co-authors) to the following:
1- I (we) hereby assign to the publisher of the journal. Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) the right to (Electronically and print) publish on website www.ayurline.in and distribute the said manuscript and to create a derivative print work from the said manuscript. The assignment shall be effective so long as the manuscript is available on online networks.
2- I (we) shall remain the owner of the copyright in said manuscript. I (we) may publish the manuscript in any other journal or medium but such publication must include the notice that the manuscript was first published by Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journals including reference to the corresponding issue.
3- I (we) agree to hold the publisher of the Journal, Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) harmless for any unauthorized use of the paper by the journal subscribers.
4- I (we) confirm that I (we) have obtained all the necessary all permissions to include in the paper items such as quotations, figures, and the results of government-sponsored research/private or individual publishers/owners.
5- I (we) enclose where necessary written permission of authors and publishers to use any copyright material (previously published figures and tables).
6- I (we) confirm that after the publication of my (our) manuscript in Ayurline: International Journal of Research in Indian Medicine (IJ-RIM), the publisher has the sole authority of the paper/Research Article. The publisher has the authority to use the content of the whole paper or part of it, in an edited book, or other mediums or withdraw (unpublish) the article without the permission of authors.
8- If I / We found victims of plagiarism, (साहित्यिक चोरी) (e.g. text, images, videos etc.) I/ We sole responsible for such legal matters. I/We also declared that the Chief Editor/Publisher, Editorial Board of this Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journal does not have any responsibility for plagiarism. Publisher shall not become any party in any legal matter and if any case is filed in court against plagiarisms or any copyright-related issues all expenses/Penalties should be paid/borne by me/we (Authors). I shall be obliged to pay all the costs of the court case if any happened in future.
7 -I voluntarily agreed to pay the necessary non-refundable evaluation fees of the my article, which are not the publication Charges.
8 - All disputes subject to Kurla, Mumbai court jurisdiction. This Copyright Licensing Agreement comes into force the day of sending this completed electronic form.
